1.2k total citations 34 papers, 1.0k citations indexed
About
Salmon Se is a scholar working on Oncology, Molecular Biology and Hematology.
According to data from OpenAlex, Salmon Se has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Salmon Se's work include Multiple Myeloma Research and Treatments (8 papers), Cancer Treatment and Pharmacology (8 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Salmon Se is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Cancer Treatment and Pharmacology (8 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Salmon Se collaborates with scholars based in United States. Salmon Se's co-authors include Alberts Ds, Hamburger Aw, Meyskens Fl, Von Hoff, B Soehnlen, Lai-Sang Young, Jones Se, Shadduck Rk, Albert Schilling and Emilio Gil‐Martín and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
In The Last Decade
Salmon Se
34 papers
receiving
881 citations
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
This map shows the geographic impact of Salmon Se's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salmon Se with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salmon Se more than expected).
This network shows the impact of papers produced by Salmon Se. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salmon Se. The network helps show where Salmon Se may publish in the future.
Co-authorship network of co-authors of Salmon Se
This figure shows the co-authorship network connecting the top 25 collaborators of Salmon Se.
A scholar is included among the top collaborators of Salmon Se based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Salmon Se. Salmon Se is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Se, Salmon, et al.. (1996). Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesis.. PubMed. 44. 97–101.27 indexed citations
2.
Jagannath, Sundar, et al.. (1994). Hemopoietic stem cell transplants for multiple myeloma.. PubMed. 8(11). 89–103; discussion 103.12 indexed citations
3.
Lebl, Michal, et al.. (1993). Preparation of large peptide libraries with one peptide per bead and their use for the discovery of peptides that bind to acceptors.. PubMed. 134. 75–83.1 indexed citations
4.
Se, Salmon & Von Hoff. (1981). In vitro evaluation of anticancer drugs with the human tumor stem cell assay.. PubMed. 8(4). 377–85.45 indexed citations
5.
O’Mara, Robert E., et al.. (1981). High-risk thyroid cancer. Prolonged survival with early multimodality therapy.. PubMed. 4(1). 67–73.7 indexed citations
6.
Se, Salmon, et al.. (1980). Clinical correlations of in vitro drug sensitivity.. PubMed. 48. 223–45.58 indexed citations
7.
Ds, Alberts, et al.. (1980). In vitro drug assay: pharmacologic considerations.. PubMed. 48. 197–207.41 indexed citations
8.
Aw, Hamburger, Salmon Se, & Alberts Ds. (1980). Development of a bioassay for ovarian carcinoma colony-forming cells.. PubMed. 48. 63–73.9 indexed citations
9.
Se, Salmon. (1980). Cloning of Human tumor stem cells: background and overview.. PubMed. 48. 3–13.9 indexed citations
10.
Se, Salmon, et al.. (1980). Soft agar-methylcellulose assay for human bladder carcinoma.. PubMed. 48. 75–83.3 indexed citations
11.
Se, Salmon, et al.. (1980). Variables in the demonstration of human tumor clonogenicity: cell interactions and semi-solid support.. PubMed. 48. 127–34.2 indexed citations
12.
Se, Jones, et al.. (1980). Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy.. PubMed. 64(2-3). 269–73.15 indexed citations
13.
Aw, Hamburger, et al.. (1980). Soft-agar cloning of cells from patients with lymphoma.. PubMed. 48. 43–52.4 indexed citations
14.
Ph, Bartels, et al.. (1979). Discrimination between human T and B lymphocytes by computer analysis of digitized data from scanning microphotometry. II. Discrimination and automated classification.. PubMed. 22(6). 530–7.2 indexed citations
15.
Se, Salmon, et al.. (1978). A new basis for treatment of multiple myeloma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 108(41). 1568–72.1 indexed citations
16.
Aw, Hamburger, et al.. (1978). Direct cloning of human ovarian carcinoma cells in agar.. PubMed. 38(10). 3438–44.256 indexed citations
17.
Se, Jones, et al.. (1977). Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung.. PubMed. 61(5). 875–9.11 indexed citations
18.
Se, Salmon. (1976). Nitrosoureas in multiple myeloma.. PubMed. 60(6). 789–94.26 indexed citations
19.
Se, Salmon. (1973). Immunoglobulin synthesis and tumor kinetics of multiple myeloma.. PubMed. 10(2). 135–44.122 indexed citations
20.
Se, Salmon, Shadduck Rk, & Albert Schilling. (1967). Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma.. PubMed. 51(3). 179–87.38 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.